375 related articles for article (PubMed ID: 17990062)
1. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.
Klepac N; Relja M; Klepac R; Hećimović S; Babić T; Trkulja V
J Neurol; 2007 Dec; 254(12):1676-83. PubMed ID: 17990062
[TBL] [Abstract][Full Text] [Related]
2. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
[TBL] [Abstract][Full Text] [Related]
3. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
4. Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study.
Tang Q; Liu H; Shi XJ; Cheng Y
Oxid Med Cell Longev; 2020; 2020():9187195. PubMed ID: 32963705
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and plasma aminopeptidase activity in Huntington's disease.
Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
J Neural Transm (Vienna); 2010 Mar; 117(3):325-32. PubMed ID: 20094738
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
Stoy N; Mackay GM; Forrest CM; Christofides J; Egerton M; Stone TW; Darlington LG
J Neurochem; 2005 May; 93(3):611-23. PubMed ID: 15836620
[TBL] [Abstract][Full Text] [Related]
7. Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
Mol Genet Metab; 2008 Mar; 93(3):341-6. PubMed ID: 18006350
[TBL] [Abstract][Full Text] [Related]
8. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
9. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.
Sánchez-López F; Tasset I; Agüera E; Feijóo M; Fernández-Bolaños R; Sánchez FM; Ruiz MC; Cruz AH; Gascón F; Túnez I
Neurol Res; 2012 Sep; 34(7):721-4. PubMed ID: 22889672
[TBL] [Abstract][Full Text] [Related]
11. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of mitochondrial function in Huntington's disease muscle.
Turner C; Cooper JM; Schapira AH
Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
[TBL] [Abstract][Full Text] [Related]
13. Plasma homovanillic acid and prolactin in Huntington's disease.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
Neurochem Res; 2009 May; 34(5):917-22. PubMed ID: 18841471
[TBL] [Abstract][Full Text] [Related]
14. NGF and nitrosative stress in patients with Huntington's disease.
Tasset I; Sánchez-López F; Agüera E; Fernández-Bolaños R; Sánchez FM; Cruz-Guerrero A; Gascón-Luna F; Túnez I
J Neurol Sci; 2012 Apr; 315(1-2):133-6. PubMed ID: 22251933
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CAG repeat expansion in Huntington's disease gene (IT 15) in a Hungarian population.
Jakab K; Gárdián G; Endreffy E; Kalmár T; Bachrati C; Vécsei L; Raskó I
Eur Neurol; 1999; 41(2):107-10. PubMed ID: 10023115
[TBL] [Abstract][Full Text] [Related]
16. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.
Vymazal J; Klempír J; Jech R; Zidovská J; Syka M; Růzicka E; Roth J
J Neurol Sci; 2007 Dec; 263(1-2):20-5. PubMed ID: 17585943
[TBL] [Abstract][Full Text] [Related]
17. CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients.
Stevanin G; Camuzat A; Holmes SE; Julien C; Sahloul R; Dodé C; Hahn-Barma V; Ross CA; Margolis RL; Durr A; Brice A
Neurology; 2002 Mar; 58(6):965-7. PubMed ID: 11914418
[TBL] [Abstract][Full Text] [Related]
18. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characteristics of Mexican Huntington's disease patients.
Alonso ME; Ochoa A; Boll MC; Sosa AL; Yescas P; López M; Macias R; Familiar I; Rasmussen A
Mov Disord; 2009 Oct; 24(13):2012-5. PubMed ID: 19672992
[TBL] [Abstract][Full Text] [Related]
20. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
Chang KH; Wu YR; Chen YC; Chen CM
Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
